Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin

被引:371
作者
Urbanek, M
Legro, RS
Driscoll, DA
Azziz, R
Ehrmann, DA
Norman, RJ
Strauss, JF
Spielman, RS [1 ]
Dunaif, A
机构
[1] Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA
[2] Univ Penn, Sch Med, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA
[3] Penn State Univ, Milton S Hershey Med Ctr, Coll Med, Dept Obstet & Gynecol, Hershey, PA 17033 USA
[4] Univ Alabama, Dept Med, Birmingham, AL 35233 USA
[5] Univ Alabama, Dept Obstet & Gynecol, Birmingham, AL 35233 USA
[6] Univ Chicago, Pritzker Sch Med, Dept Med, Chicago, IL 60637 USA
[7] Univ Adelaide, Reprod Med Unit, Woodville, SA 5011, Australia
[8] Brigham & Womens Hosp, Div Womens Hlth, Boston, MA 02115 USA
关键词
D O I
10.1073/pnas.96.15.8573
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Polycystic ovary syndrome (PCOS) is a common endocrine disorder of women, characterized by hyperandrogenism and chronic anovulation. It is a leading cause of female infertility and is associated with polycystic ovaries, hirsutism, obesity, and insulin resistance. We tested a carefully chosen collection of 37 candidate genes for linkage and association with PCOS or hyperandrogenemia in data from 150 families. The strongest evidence for linkage was with the follistatin gene, for which affected sisters showed increased identity by descent (72%; chi(2) = 12.97; nominal P = 3.2 x 10(-4)). After correction for multiple testing (33 tests), the follistatin findings were still highly significant (P-c = 0.01). Although the linkage results for CYP11A were also nominally significant (P = 0.02), they were no longer significant after correction. In 11 candidate gene regions, at least one allele showed nominally significant evidence for population association with PCOS in the transmission/disequilibrium test (chi(2) greater than or equal to 3.84; nominal P < 0.05). The strongest effect in the transmission/disequilibrium test was observed in the INSR region (D19S884; allele 5; chi(2) = 8.53) but was not significant after correction. Our study shows how a systematic screen of candidate genes can provide strong evidence for genetic linkage in complex diseases and can identify those genes that should have high (or low) priority for further study.
引用
收藏
页码:8573 / 8578
页数:6
相关论文
共 41 条
[11]   EVIDENCE FOR DISTINCTIVE AND INTRINSIC DEFECTS IN INSULIN ACTION IN POLYCYSTIC-OVARY-SYNDROME [J].
DUNAIF, A ;
SEGAL, KR ;
SHELLEY, DR ;
GREEN, G ;
DOBRJANSKY, A ;
LICHOLAI, T .
DIABETES, 1992, 41 (10) :1257-1266
[12]   Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis [J].
Dunaif, A .
ENDOCRINE REVIEWS, 1997, 18 (06) :774-800
[13]   The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome [J].
Dunaif, A ;
Scott, D ;
Finegood, D ;
Quintana, B ;
Whitcomb, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (09) :3299-3306
[14]  
EWENS WJ, 1995, AM J HUM GENET, V57, P455
[15]   MEDICAL PROGRESS - POLYCYSTIC-OVARY-SYNDROME [J].
FRANKS, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (13) :853-861
[16]   Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism [J].
Gharani, N ;
Waterworth, DM ;
Batty, S ;
White, D ;
GillingSmith, C ;
Conway, GS ;
McCarthy, M ;
Franks, S ;
Williamson, R .
HUMAN MOLECULAR GENETICS, 1997, 6 (03) :397-402
[17]   5' polymorphism of the CYP17 gene is not associated with serum testosterone levels in women with polycystic ovaries [J].
Gharani, N ;
Waterworth, DM ;
Williamson, R ;
Franks, S .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (11) :4174-4174
[18]   FAMILIAL POLYCYSTIC OVARIAN DISEASE [J].
GIVENS, JR .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1988, 17 (04) :771-783
[19]   Polycystic ovaries are inherited as an autosomal dominant trait: Analysis of 29 polycystic ovary syndrome and 10 control families [J].
Govind, A ;
Obhrai, MS ;
Clayton, RN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (01) :38-43
[20]   Overexpression of mouse follistatin causes reproductive defects in transgenic mice [J].
Guo, QX ;
Kumar, TR ;
Woodruff, T ;
Hadsell, LA ;
DeMayo, FJ ;
Matzuk, MM .
MOLECULAR ENDOCRINOLOGY, 1998, 12 (01) :96-106